ID | Age yrs | Sex | NanoString diagnosis | Orthogonal method | Original diagnosis | Tumor location | Meta-stases | Relapse mts/location | DOD mts | ADF mts | Primary treatment PPNG protocols | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
RT | Chemiotherapy | |||||||||||
CIC 1 ref | 0.5 | f | EFT-CIC | Methylation | PNET | fronto-temporal right | no | 5/distant | 9 | – | none | MB/PNET |
BCOR 1 ref | 1.5 | m | HGNET-BCOR | Methylation, BCOR tandem dup | PNET | frontal right | no | 8/local | 35 | – | none | MB/PNET |
BCOR 2 | 9 | m | HGNET-BCOR | BCOR immuno | GBM | pons | no | 29/local | 31 | – | local | HGG II version |
BCOR 3 | 6 | f | HGNET-BCOR | BCOR immuno | GBM | frontal right | no | no | no | 144 | local | HGG I version |
BCOR 4 | 6 | f | HGNET-BCOR | BCOR tandem dup | GBM | parietal left | no | no | no | 168 | local | HGG I version |
BCOR 5 | 2.5 | f | HGNET-BCOR | BCOR immuno | Unclassified malignant neuroepithelial tumor | cerebellar hemisphere | no | no | no | 66 | CSI | MB SR |
BCOR 6 | 8 | m | HGNET-BCOR | BCOR tandem dup | Anaplastic oligodendroglioma | frontal lobe left | no | 22/local | 24tox | – | local | HGG I version |
MN1 ref | 2 | f | HGNET-MN1 | Methylation, MN1:BEND2 fusion | PNET | parieto-temporal right | no | no | no | 144 | none | MB/PNET |
MN2 | 9 | f | HGNET-MN1 | MN1:BEND2 fusion | EPN | frontal lobe right | no | no | no | 204 | local | HGG I version |
MN3 | 11 | f | HGNET-MN1 | MN1:BEND2 fusion | Papillary EPN | parietal left | no | no | no | 132 | local | none |
MN4 | 6 | f | HGNET-MN1 | MN1:BEND2 fusion | CPC | parietal right | no | no | no | 180 | local | CPC |
FOXR2 1 ref | 5 | f | NB-FOXR2 | Methylation | PNET | parietal left | yes | no | no | 120 | CSI | MB/PNET |
FOXR2 2 ref | 4.5 | m | NB-FOXR2 | Methylation | PNET | parieto-occipital left | no | no | no | 137 | CSI | MB/PNET |
FOXR2 3 | 7 | m | NB-FOXR2 | nd | PNET | frontal right | no | no | no | 240 | CSI | MB/PNET |